ZFIN ID: ZDB-FISH-150901-10580
Fish name: AB + MO3-sparc
Genotype: AB
Targeting Reagent: MO3-sparc

HUMAN DISEASE MODELED by AB + MO3-sparc
No data available
GENE EXPRESSION
Gene expression in AB + MO3-sparc
Expressed Gene Structure Conditions Figures
atp1a1a.4 anterior crista primordium, dorsolateral septum, (not) lateral crista primordium (all 4) expand standard conditions Fig. 7Fig. 8 from Rotllant et al., 2008
cldna otic vesicle standard conditions Fig. 6 from Rotllant et al., 2008
col2a1a chondrocyte, cranial cartilage, (not) notochord (all 4) expand standard conditions Fig. 4Fig. 8 from Rotllant et al., 2008
dlx2a chondrocranium cartilage, cranial neural crest cell, mandibular arch skeleton (all 5) expand standard conditions Fig. 4 from Rotllant et al., 2008
dlx3b otic vesicle standard conditions Fig. 6 from Rotllant et al., 2008
eya1 otic vesicle standard conditions Fig. 6 from Rotllant et al., 2008
gata1a anatomical structure, blood island, intermediate cell mass of mesoderm control Fig. 2 from Ceinos et al., 2013
hbbe3 anatomical structure, erythroid lineage cell control Fig. 2 from Ceinos et al., 2013
lcp1 myeloid cell control Fig. 2 from Ceinos et al., 2013
msx3 anterior crista primordium, (not) lateral crista primordium, posterior crista primordium standard conditions Fig. 7Fig. 8 from Rotllant et al., 2008
myb anterior lateral mesoderm, hematopoietic system, intermediate cell mass of mesoderm (all 4) expand control Fig. 3 from Ceinos et al., 2013
otx1b (not) otic vesicle standard conditions Fig. 6Fig. 8 from Rotllant et al., 2008
rag1 thymus control Fig. 2 from Ceinos et al., 2013
runx1 anterior lateral mesoderm, blood island, hematopoietic system (all 5) expand control Fig. 4 from Ceinos et al., 2013
sox9a chondrocranium cartilage, otic vesicle, pharyngeal arch standard conditions Fig. 4 from Rotllant et al., 2008
sox9b chondrocranium cartilage, rhombomere standard conditions Fig. 4 from Rotllant et al., 2008
sparc whole organism standard conditions Fig. 3 from Rotllant et al., 2008
spi1b anterior lateral mesoderm, intermediate cell mass of mesoderm control Fig. 2 from Ceinos et al., 2013
stm otic vesicle standard conditions Fig. 6 from Rotllant et al., 2008
PHENOTYPE 
Phenotype in AB + MO3-sparc
Phenotype Conditions Figures
anatomical structure gata1a expression decreased amount, abnormal control Fig. 2 from Ceinos et al., 2013
anatomical structure hbbe3 expression decreased amount, abnormal control Fig. 2 from Ceinos et al., 2013
anterior macula position, abnormal standard conditions Fig. 7 from Rotllant et al., 2008
anterior semicircular canal aplastic, abnormal standard conditions Fig. 7 from Rotllant et al., 2008
blood island gata1a expression decreased amount, abnormal control Fig. 2 from Ceinos et al., 2013
ceratobranchial cartilage aplastic, abnormal standard conditions Fig. 4Fig. 8 from Rotllant et al., 2008
ceratohyal cartilage aplastic, abnormal standard conditions Fig. 4 from Rotllant et al., 2008
ceratohyal cartilage decreased size, abnormal standard conditions Fig. 4Fig. 8 from Rotllant et al., 2008
chondrocranium cartilage decreased size, abnormal standard conditions Fig. 4 from Rotllant et al., 2008
cranial cartilage morphology, abnormal standard conditions Fig. 4 from Rotllant et al., 2008
erythrocyte differentiation decreased occurrence, abnormal control Fig. 2 from Ceinos et al., 2013
erythroid lineage cell hbbe3 expression decreased amount, abnormal control Fig. 2 from Ceinos et al., 2013
immature posterior macula aplastic, abnormal standard conditions Fig. 6Fig. 8 from Rotllant et al., 2008
inner ear decreased size, abnormal standard conditions Fig. 7 from Rotllant et al., 2008
inner ear morphogenesis disrupted, abnormal standard conditions Fig. 7Fig. 8 from Rotllant et al., 2008
intermediate cell mass of mesoderm gata1a expression decreased amount, abnormal control Fig. 2 from Ceinos et al., 2013
intermediate cell mass of mesoderm apoptotic process occurrence, normal control Fig. 5 from Ceinos et al., 2013
intermediate cell mass of mesoderm cell proliferation increased occurrence, abnormal control Fig. 5 from Ceinos et al., 2013
lateral crista primordium aplastic, abnormal standard conditions Fig. 7Fig. 8 from Rotllant et al., 2008
lateral semicircular canal aplastic, abnormal standard conditions Fig. 7 from Rotllant et al., 2008
Meckel's cartilage aplastic, abnormal standard conditions Fig. 4Fig. 8 from Rotllant et al., 2008
Meckel's cartilage decreased size, abnormal standard conditions Fig. 4 from Rotllant et al., 2008
notochord morphology, abnormal standard conditions Fig. 8 from Rotllant et al., 2008
otic vesicle formation disrupted, abnormal standard conditions Fig. 6Fig. 8 from Rotllant et al., 2008
otolith present, normal standard conditions Fig. 7 from Rotllant et al., 2008
pectoral fin decreased size, abnormal standard conditions Fig. 4 from Rotllant et al., 2008
pectoral fin kinked, abnormal standard conditions Fig. 4 from Rotllant et al., 2008
pectoral fin cartilage morphology, abnormal standard conditions Fig. 4 from Rotllant et al., 2008
posterior macula position, abnormal standard conditions Fig. 7 from Rotllant et al., 2008
posterior semicircular canal aplastic, abnormal standard conditions Fig. 7 from Rotllant et al., 2008
trunk apoptotic process increased occurrence, abnormal control Fig. 5 from Ceinos et al., 2013
ventral mandibular arch decreased size, abnormal standard conditions Fig. 4 from Rotllant et al., 2008
vestibuloauditory system functionality, abnormal standard conditions Fig. 4 from Rotllant et al., 2008
whole organism curved dorsal, abnormal standard conditions Fig. 8 from Rotllant et al., 2008
whole organism decreased length, abnormal standard conditions Fig. 4 from Rotllant et al., 2008
whole organism lethal (sensu genetics), abnormal standard conditions text only from Rotllant et al., 2008

CITATIONS  (3)